NONSEGMENTAL VITILIGO
Clinical trials for NONSEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NONSEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NONSEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new pill may help reverse white patches in vitiligo
Disease control OngoingThis study tests a daily pill called povorcitinib in 450 adults with nonsegmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the drug can safely restore color, especially on the face, over 52 weeks. Participants stop all other vitiligo trea…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New pill shows promise for restoring skin color in vitiligo
Disease control OngoingThis study tests a daily pill called povorcitinib in 467 adults with nonsegmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the drug can safely improve skin color, especially on the face, compared to a placebo over 52 weeks. Participants m…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 19, 2026 11:47 UTC